Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus - Ages 8-17
Are you the parent of a child that has developed type 1 diabetes (T1D) within the last 3 months. Your child may be eligible to join a research study testing a drug called Rezpegaldesleukin to see if it will preserve insulin secretion after diagnosis of type 1 diabetes (T1D). After screening, if your child is eligible and decides to enroll, participation will be for about one year.